Therapeutic strategies for hepatic fibro
โ
Mario Chojkier; David A. Brenner
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 911 KB
The mechanisms responsible for the increased hepatic connective tissue deposition in cirrhosis remain unknown; and there is no established therapy for hepatic fibrosis. In this issue of Hepatology, Ruwart et al. (1) report that 16,16-dimethyl prostaglandin E2 (DMPG) inhibits hepatic collagen deposit